Ramreddy Meka's insights shed light on a future where technology not only sustains but significantly enhances the quality of ...

scPharmaceuticals Inc. (NASDAQ: SCPH) Q3 2024 Earnings Call Transcript November 13, 2024 ...

Diabetes cannot prevent you from getting a policy. You must disclose it as a pre-existing illness, but insurers cannot deny ...

scPharmaceuticals Inc. ( NASDAQ: SCPH) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior ...

NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...

NIHR study tackles multiple long-term conditions in Sri Lanka: United Kingdom Friday, November 15, 2024, 16:00 Hrs [IST] A team of health experts from the University of Birmingham ...

Patient experience and care is being improved in Sri Lanka thanks to funding from the National Institute for Health and Care ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions ...

Columnist Anna Jeter explains how reproductive healthcare was ingrained in both her PH treatment plan and her post-transplant ...

In addition, as we accrue more experience and data with lorundrostat, we plan to continue to ... will be relevant to primary ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

The University of Vermont Health Network has shared plans for significant clinical services and administrative reductions.